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First described in 1839, a ruptured sinus of Valsalva aneurysm (RSVA) is a rare but well-known clinical condition, with the rupture 
usually occurring in the right-sided cardiac chamb-
er.1,2 These types of aneurysms are thin-walled sac- 
cular or tubular outpouchings of the aortic sinuses 
and can be either congenital or acquired.2 Echo-
cardiography can accurately identify these lesions and 
confirm a diagnosis of RSVA. Cardiac surgical repair 
is the conventional method of treatment; however, 
trans-catheter closure has more recently been deemed 
the optimal choice of treatment.3 This report presents 
two cases of RSVA in which transcatheter closure was 
used. Complete closure of the defect was achieved in 
the first case. For the second case, which involved a 
patient with a multifenestrated aneurysmal defect, two 
devices were used during catheterisation. However, 
complete closure could not be achieved.
Case 1
A 45 year-old female with no known medical con-
ditions presented to the Emergency Department of 
the Royal Hospital, Muscat, Oman, in 2014 with a 
one-day history of chest pain and shortness of breath. 
There was no history of fever. Her blood pressure 
was 120/55 mmHg and her heart rate was 85 beats 
per minute. A clinical examination revealed normal 
heart sounds, although a continuous murmur was 
audible over the third left intercostal space. An 
electrocardiogram and chest X-ray were normal with 
no features suggestive of a myocardial infarction. Her 
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abstract: A ruptured sinus of Valsalva aneurysm (RSVA) is a rare cardiac anomaly. Traditionally, RSVAs were 
repaired surgically; however, percutaneous transcatheter closure is the current treatment of choice. We report two 
cases of RSVA which were closed using this approach. The first case was a 45-year-old female who presented to the 
Royal Hospital, Muscat, Oman, in 2014 with a RSVA in the right ventricle. The second case was a 39-year-old male 
who was admitted to the Sultan Qaboos University Hospital, Muscat, in 2015 with a large multifenestrated RSVA 
extending into the right ventricle outflow tract. Each patient underwent transcutaneous cardiac catheterisation 
using three-dimensional echocardiography. Both interventions were technically successful; however, the second 
patient required a subsequent surgery due to the continuing presence of a significant shunt. Transcatheter closure 
of RSVAs is an effective alternative to surgical repair, although large multifenestrated RSVAs should be repaired 
surgically to ensure complete closure.
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امللخ�ص:متزق جيب ف�ل�ش�لف� الوع�ئي الدموي املتمدد هو عيب خلقي ن�در يحدث يف القلب, ويف الع�دة يتم اإ�شالح هذا التمزق جراحي� 
ولكن يف الوقت الراهن ميكن اإغالقه بوا�شطة الق�شطرة التداخلية. نعر�س يف هذا التقرير �رسح حل�لتني مت ا�شتخدام الطريقة احلديثة يف 
العالج, احل�لة الأوىل هي ملري�شة تبلغ من العمر 45 ع�مً� متت مع�ينته� ب�مل�شت�شفى ال�شلط�ين يف ع�م 2015  ومت ت�شخي�شه�  بتمزق  يف 
جيب ف�ل�ش�لف� الوع�ئي الدموي املتمدد يف منطقة البطني الأمين للقلب, اأم� احل�لة الث�نية فهي ملري�س يبلغ من العمر 39 ع�م� مت تقييمه 
يف م�شت�شفى ج�معة ال�شلط�ن ق�بو�س ووجد لديه متزق كبري يف جيب ف�ل�ش�لف� متمدد وذو فتح�ت متعددة جهة خمرج البطني الأمين, كال 
احل�لتني خ�شعت� لإجراء ق�شطرة تداخلية لإ�شالح التمزق وذلك مب�ش�ندة تخطيط ال�شدى ثالثي الأبع�د للقلب, ك�نت التدخالت للح�لتني 
ن�جحة من الن�حية الفنية, اإل اأن املري�س الث�ين تطلب اإجراء عملية جراحية لحقة نتيجة ل�شتمرار تدفق الدم للبطني الأمين نتيجة لوجود 
عدة فتح�ت �شغرية. اإن اأغالق متزق جيب ف�ل�ش�لف� الوع�ئي املتمدد بطريقة الق�شطرة التداخلية هو بديل فع�ل عن التدخل اجلراحي اإل اأنه 
يف ح�لت التمزق متعدد الفتح�ت والأكرب حجم� ف�إنه ين�شح ب�أن يع�لج جراحي� ل�شم�ن الإغالق الك�مل ملك�ن التمزق.
الكلمات املفتاحية: متزق جيب ف�ل�ش�لف�, متدد ف�ل�ش�لف� الوع�ئي, ق�شطرة قلبية, تخطيط  القلب ب�ل�شدى ثالثي الأبع�د, تقرير ح�لة, عم�ن.
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troponin T levels were within the expected range 
(<5 pg/mL). Transthoracic echocardiography (TTE) 
and transoesophageal echocardiography (TOE) reveal-
ed a RSVA extending from the right sinus into the 
right ventricle under the septal leaflet of the tricuspid 
valve. The aneurysm had a windsock appearance, with 
the aortic end measuring 10 mm and the opening 
into the right ventricle measuring 6 mm [Figure 1A]. 
She had a trileaflet aortic valve with no regurgitation. 
No ventricular septal defects, pericardial effusions or 
intracardiac vegetations were seen. The right and left 
ventricles were not dilated and demonstrated normal 
systolic function. 
After discussion with cardiothoracic surgeons, a 
transcutaneous cardiac catheterisation intervention 
was performed. The patient was put under general 
anaesthesia, with the right femoral artery and vein 
punctured and a 6F short sheath secured. Unfract-
ionated heparin and cefradine were administered 
intravenously at doses of 100 IU/kg and 1,000 mg, 
respectively. Two- and three-dimensional TOE scans 
confirmed the previous echocardiographic findings 
and haemodynamic data showed an increased left 
ventricular end-diastolic pressure of 15 mmHg and 
a pulmonary to systemic blood flow (Qp:Qs) ratio of 
3:1. An aortic root angiogram clearly delineated the 
RSVA, which was located far away from the right 
coronary artery with similar measurements to those 
observed via TOE. The RSVA was closed using a size 
12/10 Cocoon Duct Occluder (Aeon World Group 
Corp., Taguig City, Manila, Philippines), which was 
inserted antegradely from the venous side. The RSVA 
was crossed from the aortic side with a 5F Cordis™ 
Judkins Right JR4 catheter (Cordis Corp., California, 
USA) using 0.89 mm x 260 cm of guidewire (Terumo 
Interventional Systems, Terumo Medical Corp., Tokyo, 
Japan). An arteriovenous loop was established after 
the wire was snared from the left pulmonary artery. 
A 7F Mullins sheath (Cook Group, Bloomington, 
Indiana, USA) was placed into the ascending aorta 
before the occluder was introduced; the skirt of the 
device was opened in the ascending aorta under 
fluoroscopic and TOE guidance. The device was pulled 
as one unit into the RSVA and the sheath retracted 
over the cable to deploy the rest of the device. Three-
dimensional TOE and an angiogram confirmed that 
the device was in a satisfactory position, with minimal 
flow through the device and no aortic valve regur-
gitation [Figures 1B and C]. 
The following day, TTE confirmed that the device 
was well-positioned, with total occlusion of the RSVA 
and no aortic or tricuspid valve regurgitation. The 
patient was discharged and prescribed a six-month 
course of aspirin (5 mg/kg per day) and a two-month 
course of clopidogrel (75 mg per day), with close 
follow-up.
Case 2
A 39-year-old man was admitted to the Sultan 
Qaboos University Hospital, Muscat, in 2015 with a 
two-month history of chest pain, shortness of breath 
and exercise intolerance. Clinically, he showed signs 
of aortic regurgitation, with an early diastolic murmur 
along the left sternal border. Using TTE, a RSVA 
extending into the right ventricular outflow tract 
(RVOT) was observed, with a dilated left ventricle. A 
mitral annulus (5 cm) and mild mitral and aortic valve 
regurgitation were also noted. The aneurysm had 
two large fenestrations of 8 mm in diameter each, in 
addition to multiple smaller defects. The mouth of the 
main aneurysm was 17 mm in diameter and the right 
coronary artery was in close proximity to the opening 
of the aneurysm. The aneurysm protruded into the 
RVOT but did not obstruct it. 
The patient underwent transcutaneous cardiac 
catheterisation of the ruptured aneurysm under TOE 
guidance with on-site surgical back-up. A TOE scan 
 
Figure 1: A: Two-dimensional transoesophageal echocardiography (TOE) in the short axis view showing a right sinus 
of Valsalva aneurysm (RSVA) extending into the right ventricle (arrow) of a 45-year-old female patient. B: Post-closure 
three-dimensional TOE in the short axis view showing the position of a cardiac catheter device (arrow) across the 
aneurysm. C: Post-closure lateral fluoroscopy showing the satisfactory position of the device (arrow), with no residual 
shunts or aortic valve regurgitation.
RV = right ventricle.
Khalfan S. Al-Senaidi, Abdullah Al-Farqani, Madan Maddali and Salim Al-Maskary
Online Case Report | e513
 
Figure 2: A: Two-dimensional transoesophageal echocardiography (TOE) in the short axis view showing a multifenestrated 
right sinus of Valsalva aneurysm (RSVA) into the right ventricular outflow tract (arrow) of a 39-year-old male patient. 
B: Post-closure three-dimensional TOE in the short axis view showing the position of two cardiac catheter devices 
(short arrow) across the aneurysm, with the right ventricular outflow tract wide open. C: Post-closure lateral fluoroscopy 
showing the position of the devices.
RVOT = right ventricular outflow tract.
Discussion
Congenital RSVAs account for 0.1–3.5% of congen-
ital heart defects and have a higher incidence in Asian 
versus Western populations.3,4 These aneurysms 
usually rupture into the right side of the heart, 
producing a left-to-right shunt which has a profound 
haemodynamic effect.3 Drainage sites can be single 
or multiple, with the right ventricle being the most 
common.5 Previous research has described a wide 
spectrum of presentations, ranging from an asymp-
tomatic murmur to cardiogenic shock or even 
sudden cardiac death.5 Lillehei et al. reported the 
first successful repair of RSVAs for three patients in 
1957.6 Traditionally, surgical closure has been the 
mainstay of treatment for RSVAs, with an operative 
mortality rate of <5% and excellent long-term 
outcomes.4,7 Nevertheless, these patients remain at 
risk of prolonged hospital stays and postoperative 
complications such as chest pain and septicaemia, 
making percutaneous device closure an attractive 
alternative.4 The transcatheter closure of a RSVA was 
first reported by Cullen et al. in 1994 using a Rashkind 
umbrella device.8 Advances in cardiac catheterisation 
technology have resulted in a wide range of devices 
and coils which can be used to close a RSVA.9–15 Retro-
grade and combined minimally invasive surgery hybrid 
approaches have been described in certain cases.16,17
Based on a retrospective review of 257 patients, 
Guo et al. proposed a new system of simple surgical 
classification for right-sided defects according to 
rupture site.18 This classification system identifies four 
types of rupture: type I, a rupture or protrusion into 
the right atrium; type II, a rupture or protrusion into 
the right atrium or right ventricle, near or at the 
tricuspid annulus; type III, a rupture or protrusion 
into the right ventricular outflow tract, under the 
pulmonary valve; and type IV, other types of ruptures 
or protusions.18 Another system of angiographic 
classification uses the shape of the left-to-right shunt 
confirmed the TTE findings and showed that the RSVA 
was 3.4 cm with a 17 mm mouth [Figure 2A]. The 
right femoral artery and vein as well as the left femoral 
artery were accessed using 8F, 10F and 6F sheaths, 
respectively. The coronary arteries were normal and 
the Qp:Qs ratio was 5.2:1, with a pulmonary vascular 
resistance index of 1.6 Wood units. As previously 
described for the first patient, the fenestrated defect 
was crossed and an arteriovenous loop established. 
The first fenestration was closed with a 23/25 mm 
Occlutech® Figulla® PFO Occluder (Occlutech 
GmbH, Jena, Germany), inserted antegradely from the 
venous side. A large shunt in the second fenestration 
was identified via TOE, necessitating the use of a 
second device; hence, an 18mm AMPLATZER™ PFO 
Occluder (St. Jude Medical Inc., St. Paul, Minnesota, 
USA) was deployed retrogradely from the arterial 
side. This device was deployed retrogradely in order 
to close the aneurysm from the RVOT towards the 
left ventricle and to secure the two devices in a more 
stable position. The right coronary artery was not 
affected by the devices and both devices were placed 
in suitable positions [Figures 2B and C]. Following the 
intervention, the Qp:Qs ratio decreased to 2.2:1 and 
TEE revealed mild aortic regurgitation.
The patient was discharged the following day, after 
a TTE scan confirmed the position of the devices. 
However, a mild-to-moderate shunt was present 
across the aneurysm, with no RVOT obstruction. The 
mild aortic regurgitation persisted. The patient was 
prescribed 75 mg of aspirin daily for six months and 
75 mg of clopidogrel daily for two months. On follow-
up, the patient reported significant improvement 
in his symptoms. Echocardiography confirmed that 
the two devices were still in a satisfactory position 
across the aneurysm with no RVOT obstruction; 
however, there was a significant shunt across the other 
small defects. The patient subsequently underwent 
successful surgical correction of the aneurysm a few 
months later. 
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jet in order to facilitate the selection of occluders for 
percutaneous closure.19 The four types of shunt jets 
identified are: type I, window-like; type II, aneur- 
ysmal; type III, tubular; and type IV, other rare 
conditions.19 With regards to the current cases, the 
first patient had a type III shunt jet and the second 
patient had a type II shunt jet. 
The current report describes two patients with 
RSVAs in which a transcatheter approach was used 
to close the aneurysms. In the first case, the RSVA 
was closed using an occluder made of platinum-
coated nitinol wires. This is a self-expanding double-
disk device connected by a joint at the centre of the 
disks, which are filled with polypropylene fabric to 
increase thrombogenicity. Complete closure of the 
defect was achieved in this case. The second patient 
had a complex multifenestrated RSVA with two large 
defects and additional smaller defects. The RSVA 
penetrated into the RVOT and required two devices 
to close the larger defects. Initially, the interventionist 
intended to close the aneurysm at its entry point; 
however, due to the close proximity of the right 
coronary ostia to the mouth of the aneurysm, it was 
decided to close the RSVA at the exit point instead. 
Patent foramen ovale occluders were used as they have 
large retention discs on both sides which are nearly 
equal in size. As the aneurysm was multifenestrated, 
the devices were positioned in order to cover as many 
of the smaller defects as possible. Nevertheless, the 
patient continued to experience a significant shunt 
through the small defects and was referred for further 
surgical correction. These two cases demonstrate 
the two extremes of RSVA in terms of complexity. 
As observed with the second patient, large multi-
fenestrated RSVAs should be closed surgically—if 
closure at the point of entry is not possible—in order 
to prevent the occurrence of smaller defects. In most 
cases of RSVA, the coronary ostia are quite high 
and device impingement occurs rarely. Ventricular 
septal defects often coexist with RSVAs, especially in 
patients with significant aortic valve regurgitation.20 
Thankfully, neither patient in the current report had a 
ventricular septal defect. 
Conclusion
Transcatheter closure is a safe and effective 
treatment option for patients with RSVAs. Real-time 
three-dimensional echocardiography allows easy 
visualisation of the defect and is helpful in guiding 
deployment of the device. However, surgical repair 
is recommended for large multifenestrated defects 
to prevent the development of further small defects 
after closure. The long-term follow-up of RSVA 
patients is mandatory to ensure complete closure of 
the aneurysm.
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